Company Overview

PRIME exits® and American HealthCare Capital are pleased to exclusively introduce an established provider of medical equipment repair, preventive maintenance, refurbishment, and technical support services. The Company serves healthcare organizations throughout the United States, helping customers extend the useful life of essential medical equipment, reduce replacement costs, and minimize operational downtime.

The Company has developed long-standing customer relationships through responsive service, technical expertise, competitive pricing, and consistent workmanship. Its experienced staff, in-house capabilities, and scalable operating model provide a strong foundation for continued growth through geographic expansion, new customer relationships, and additional service offerings.

Core Competencies and Differentiators

• Repair, preventive maintenance, and refurbishment of specialized medical equipment

• Comprehensive equipment inspection and diagnostic services

• High-quality repair work performed in accordance with applicable performance specifications

• In-house technical and fabrication capabilities

• Responsive service and competitive turnaround times

• Experienced technicians with specialized industry knowledge

• Quality-control testing and service documentation

• Cost-effective alternative to equipment replacement and manufacturer service programs

• Established customer relationships and repeat business

• Scalable operating model with opportunities for geographic and service-line expansion

Investment Highlights

• Revenue growth at a 27.1% CAGR from 2023 through the 2026 management forecast

• Strong gross margins ranging from 64% to 69% during the period

• Adjusted EBITDA margin projected to increase from 25% in 2023 to approximately 36% in 2026

• Essential services that help healthcare providers extend equipment life and reduce replacement costs

• Established customer relationships and repeat business

• Opportunities for continued growth through geographic expansion, new customer acquisition, and additional service offerings

• Limited capital expenditure requirements and scalable operating model

• Potential platform or add-on acquisition for strategic and financial buyers in the medical equipment services industry.

Financial Overview

The Company generated approximately $740,000 in revenue and $196,000 in Adjusted EBITDA in 2025. During the first seven months of 2026, the Company generated approximately $496,000 in revenue and $183,000 in Adjusted EBITDA. Management forecasts approximately $850,000 in revenue and $302,000 in Adjusted EBITDA for the full year, representing an Adjusted EBITDA margin of approximately 36%.

Revenue increased from approximately $414,000 in 2023 to $740,000 in 2025 and is forecasted to reach approximately $850,000 in 2026, representing a 27.1% CAGR. Gross margins ranged from 64% to 68% historically and are forecasted at approximately 69% for 2026.Based on the 2026 management forecast, revenue is projected to grow at a compound annual growth rate of 27.1% from 2023 through 2026, with gross margins ranging from 64% to 69% during the period.

Asking Price

The asking price for this opportunity is $1.2 million. This does not include cash, receivables, working capital, or real estate.